Mechanism

LPL (lipoprotein lipase) gene

Assets acting on this target.

Class
AAV gene therapy (self-complementary AAV serotype 5 vector carrying a codon-optimized LPL coding sequence under a liver-specific promoter)
Pathway
Liver-directed gene replacement restoring lipoprotein lipase activity in primary hypertriglyceridemia/LPL-deficiency patients with recurrent pancreatitis
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

1 of 1 assets

← all assets